INMB

INMB Operating Income Growth

64.08%TTM

Period ending:

INMB TTM Operating Income YoY %%
INMB TTM Operating Income YoY %336.33%-2476.86%
2018-06-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

INMB operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 33 observations from Jun 30, 2018 to Jun 30, 2026.

Inmune Bio Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
64.0844%
-4.2555%
-11.1364%
-23.6575%
-48.7973%
-20.9349%
-43.3543%
-53.855%
-45.7965%
-32.588%
-14.6044%
7.9587%
16.1659%
16.6876%
10.9834%
-25.7458%
-61.6153%
-111.6879%
-138.4183%
-105.5506%
-98.9398%
-85.0096%
-57.6685%
-55.4289%
-66.973%
31.0164%
37.6583%
33.5366%
40.9697%
-207.0456%
-1,119.07%
-1,522.7384%
-2,204.6177%

Compare operating income growth

All INMB financial metrics · INMB stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.